Departments of Ophthalmology.
Neurosurgical Sciences, University of California San Francisco, San Francisco, California, U.S.A.
Ophthalmic Plast Reconstr Surg. 2021;37(1):18-26. doi: 10.1097/IOP.0000000000001662.
Advances in surgical approaches have improved access for total or near-total resection of spheno-orbital meningiomas (SOM). Herein, the outcomes of multidisciplinary resection and reconstruction of SOM via frontotemporal orbitozygomatic craniotomy at a single institution are evaluated.
A retrospective chart review was performed of all patients with SOM who underwent joint neurosurgical and oculofacial plastic resection via frontotemporal orbitozygomatic craniotomy between January 1999 and December 2018. Demographic data, clinical presentation, risk factors for meningioma, radiographic imaging, pathology results, postoperative outcomes, and surgical complications were reviewed. The outcome measures assessed included visual acuity, pupillary function, color vision, ocular motility, visual fields, and proptosis.
A total of 48 patients were identified having had multidisciplinary frontotemporal orbitozygomatic craniotomy for SOM of which 43 met inclusion criteria. A mean follow-up period of 23.9 ± 20.4 months (range 1-60) was observed. There were 35 patients who underwent primary resection and 8 patients who had prior surgical resection. The main presenting complaints were proptosis (88%), headache (44%), and reduced vision (12%). Gross total resection was achieved in 15 patients (35%) while near-total or subtotal resection was achieved in the remainder. Histologic analysis revealed World Health Organization grade I meningioma in 72% of tumors, grade II in 23%, and grade III in 5%. Mean visual acuity (Logarithm of the Minimum Angle of Resolution) improved from 0.24 ± 0.46 preoperatively to 0.09 ± 0.13 postoperatively (p = 0.03). Surgery improved proptosis, with a reduction in mean Hertel exophthalmometry from 22.37 ± 3.78 mm to 17.91 ± 3.84 mm (p < 0.001), of which 80% had no residual proptosis or developed subsequent recurrence. Exophthalmic index calculated by radiologic evaluation also improved from a mean preoperative value of 1.32 ± 0.19 to 1.12 ± 0.13 at the 6-month interval after surgery (p < 0.001). Before surgery, 19 (45%) patients had a relative afferent pupillary reaction with improvement in 9 (24%) after surgery. Of the 14 (33%) patients with preoperative ocular motility deficit, 7 (16%) had resolution of ocular motility deficit postoperatively. The most common surgical complications were temporalis muscle atrophy with temporal hollowing (14%), wound infection (7%), neurogenic strabismus secondary to trochlear nerve palsy (5%), restrictive strabismus (5%), and aponeurotic blepharoptosis (5%).
Multidisciplinary frontotemporal orbitozygomatic for resection of SOM is a safe and effective means of tumor removal. It can provide improved visual acuity and proptosis metrics, as well as relief of optic neuropathy and ocular motility deficits.
手术方法的进步改善了蝶眶脑膜瘤(SOM)全切除或近全切除的可达性。在此,评估了在单一机构通过额颞眶颧开颅术进行多学科切除和重建 SOM 的结果。
对 1999 年 1 月至 2018 年 12 月期间通过额颞眶颧开颅术联合神经外科和眼整形科切除 SOM 的所有 SOM 患者进行了回顾性图表分析。评估了人口统计学数据、临床表现、脑膜瘤的危险因素、影像学检查结果、病理结果、术后结果和手术并发症。评估的结果包括视力、瞳孔功能、色觉、眼球运动、视野和眼球突出度。
共确定了 48 例 SOM 患者接受了多学科额颞眶颧开颅术治疗,其中 43 例符合纳入标准。观察到平均 23.9±20.4 个月(范围 1-60)的随访期。有 35 例患者行初次切除,8 例患者行术前切除。主要表现为眼球突出(88%)、头痛(44%)和视力下降(12%)。15 例患者(35%)达到大体全切除,其余患者达到近全切除或次全切除。组织学分析显示,72%的肿瘤为世界卫生组织一级脑膜瘤,23%为二级脑膜瘤,5%为三级脑膜瘤。视力(最小角度分辨率的对数)从术前的 0.24±0.46 提高到术后的 0.09±0.13(p=0.03)。手术改善了眼球突出度,Hertel 突出计测量的平均值从 22.37±3.78mm 减少到 17.91±3.84mm(p<0.001),其中 80%的患者没有残留的眼球突出或出现后续复发。术后 6 个月放射学评估计算的外展指数也从术前的平均 1.32±0.19 改善到 1.12±0.13(p<0.001)。术前有 19 例(45%)患者存在相对性传入性瞳孔反应,术后有 9 例(24%)得到改善。术前有 14 例(33%)患者存在眼球运动障碍,术后有 7 例(16%)得到缓解。最常见的手术并发症是颞肌萎缩伴颞部凹陷(14%)、伤口感染(7%)、滑车神经麻痹引起的神经性斜视(5%)、限制性斜视(5%)和腱膜性上睑下垂(5%)。
通过额颞眶颧开颅术切除 SOM 是一种安全有效的肿瘤切除方法。它可以提高视力和眼球突出度,缓解视神经病变和眼球运动障碍。